ImmunityBio (IBRX) Change in Receivables (2014 - 2026)
ImmunityBio's (IBRX) quarterly Change in Receivables came in at $700000.0 in Q1 2026, down 95.23% year-on-year from $14.7 million in Q1 2025, and down 93.37% on a QoQ basis from $10.6 million in Q4 2025.
ImmunityBio (IBRX) Change in Receivables (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 5 years of Change in Receivables data on file, last reported at $700000.0 in Q1 2026.
- On a quarterly basis, Change in Receivables fell 95.23% year-over-year to $700000.0 in Q1 2026; TTM through Mar 2026 was $26.2 million, a 54.1% increase from a year earlier, with the FY2025 full-year figure at $40.2 million, up 1603.86% from the prior year.
- Change in Receivables for Q1 2026 stood at $700000.0, down from $10.6 million in the prior quarter.
- Over the last five years, Change in Receivables for IBRX reached as high as $14.7 million in Q1 2025 and fell as low as -$1.8 million in Q4 2024.
- Historically, Change in Receivables has averaged $5.4 million across 3 years, with a median of $4.1 million in 2024.
- Across the five-year window, Change in Receivables soared 681.54% in 2025 and plunged 95.23% in 2026, its largest moves.
- Year by year, Change in Receivables stood at -$1.8 million in 2024, then surged by 681.54% to $10.6 million in 2025, then tumbled by 93.37% to $700000.0 in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were $700000.0 in Q1 2026, $10.6 million in Q4 2025, and $9.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn | 700,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 700,000.00 |
| Mar 31, 2026 | 700,000.00 |
| Dec 31, 2025 | 10.56 Mn |
| Dec 31, 2025 | 10.56 Mn |
| Sep 30, 2025 | 9.89 Mn |
| Sep 30, 2025 | 9.89 Mn |
| Jun 30, 2025 | 5.10 Mn |
| Jun 30, 2025 | 5.10 Mn |
| Mar 31, 2025 | 14.67 Mn |
| Mar 31, 2025 | 14.67 Mn |
| Dec 31, 2024 | -1.82 Mn |
| Dec 31, 2024 | -1.82 Mn |
| Sep 30, 2024 | 3.14 Mn |
| Sep 30, 2024 | 3.14 Mn |
| Jun 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.03 Mn |
| Sep 30, 2015 | 25,000.00 |
| Sep 30, 2015 | 25,000.00 |
| Jun 30, 2015 | 5,000.00 |
| Jun 30, 2015 | 5,000.00 |